Recent investment activity
KANDO id: 427546
Corporate information
Official name
Boehringer Ingelheim Venture Fund GmbH
Also known as
BIVF
Fund terms
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 1 of 1| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
|
NBE-Therapeutics AG | Biotech company focused on developing antibody-based treatments for cancer patients. | Series B |